Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Barry W. Siegel"'
Autor:
Salituro Francesco G, Vicki L. Taylor, Barry W. Siegel, Bruce M. Baron, John H. Kehne, Yaw Senyah, Harrison Boyd L, H.Steven White, Paul L.M. Van Giersbergen, Phillip L. Nyce, Christopher J. Schmidt, Michael Murawsky, Gina M. Fadayel, Timothy C. McCloskey
Publikováno v:
European Journal of Pharmacology. 323:181-192
MDL 105,519, ( E )-3-(2-phenyl-2-carboxyethenyl)-4,6-dichloro-1 H -indole-2-carboxylic acid, is a potent and selective inhibitor of [ 3 H]glycine binding to the NMDA receptor. MDL 105,519 inhibits NMDA ( N -methyl- d -aspartate)-dependent responses i
Autor:
Timothy W. Lovenberg, Margaret M. Racke, Bruce M. Baron, Amy L. Slone, Patria E. Danielson, Mark G. Erlander, Pamela E. Foye, Michael A. Rea, Joseph D. Miller, Rebecca A. Prosser, Barry W. Siegel, J. Gregor Sutcliffe, Luis de Lecea
Publikováno v:
Neuron. 11:449-458
We report the cloning and characterization of a novel serotonin receptor, designated as 5-HT 7 , which is coupled to the stimulation of adenylyl cyclase. 5-HT 7 mRNA is expressed discretely throughout the CNS, predominantly in the thalamus and hypoth
Autor:
Martin Galvan, Peter H. Boeijinga, Barry W. Siegel, Amy L. Slone, Mark W. Dudley, Bruce M. Baron
Publikováno v:
European Journal of Pharmacology. 219:9-13
In radioligand binding experiments, MDL 73147EF and MDL 74156 inhibited the binding of [ 3 H]GR65630 to 5-hydroxytryptamine 3 (5-HT 3 ) binding sites on membranes prepared from NG108-15 neuroblastoma × glioma cells. The calculated dissociation const
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 354
In studies using standard radioligands, unlabeled MDL 100,907 (R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol) has been shown to have a high degree of selectivity for the 5-HT2A receptor. The present study was und
Publikováno v:
European journal of pharmacology. 296(3)
Using transfected NIH 3T3 mouse fibroblast cell lines expressing the rat 5-HT2A and rat 5-HT2C receptor subtypes, and techniques of 2-[125I](+)-iodolysergic acid diethylamide ([125I]LSD) binding and serotonin (5-hydroxytryptamine, 5-HT)-stimulated ph
Autor:
Amy L. Slone, Matthieu Poirot, Barry W. Siegel, Bruce M. Baron, Harrison Boyd L, Salituro Francesco G, Timothy C. McCloskey, John H. Kehne, Michael G. Palfreyman, H.Steven White, Paul L.M. van Giersbergen
Publikováno v:
European journal of pharmacology. 284(1-2)
Glycine receptor antagonists have been proposed to have multiple therapeutic applications, including the treatment of stroke, epilepsy, and anxiety. The present study compared the biochemical and behavioral profiles of two strychnine-insensitive glyc
Autor:
Bruce M. Baron, Harrison Boyd L, Amy L. Slone, Stephen D. Hurt, Barry W. Siegel, Michael G. Palfreyman
Publikováno v:
European journal of pharmacology. 206(2)
A strychnine-insensitive glycine binding site is located on the N-methyl- d -aspartate (NMDA)-preferring glutamate receptor complex. Kynurenic acid analogs are antagonists at this binding site. A derivative of kynurenic acid, 5,7-dichlorokynurenic ac
Autor:
Barry W. Siegel, Walter Auclair
Publikováno v:
Science. 154:913-915
Late gastrulae of paracentrotus lividus regenerated cilia after being deciliated in hypertonic sea water. Regeneration was not affected by actinomycin D or puromycin. Actinomycin D also did not affect ciliary protein synthesis during regeneration, al
Autor:
Barry W. Siegel, Bruce M. Baron, Mark W. Dudley, Ann-Marie Ogden, Richard C. Ursillo, James Stegeman
Publikováno v:
European journal of pharmacology. 154(2)
Co-administration of desipramine and fluoxetine resulted in a 27% decline in cerebral cortical beta-adrenoceptor density after four days - a time point at which neither agent alone was effective. After 14 days, desipramine- and desipramine + fluoxeti
Autor:
Bruce M. Baron, Barry W. Siegel
Publikováno v:
Journal of neurochemistry. 53(2)
Forskolin and vasoactive intestinal polypeptide (VIP) were shown to increase cyclic AMP accumulation in a human neuroblastoma cell line, SK-N-SH cells. The α2-adrenergic agonist UK 14304 decreased forskolin-stimulated cyclic AMP levels by 40 ± 2%,